Clinical-Pharmacogenetic Predictive Models for Time to Occurrence of Levodopa Related Motor Complications in Parkinson’s Disease

The response to dopaminergic treatment in Parkinson’s disease depends on many clinical and genetic factors. The very common motor fluctuations (MF) and dyskinesia affect approximately half of patients after 5 years of treatment with levodopa. We did an evaluation of a combined effect of 16 clinical...

Descripción completa

Detalles Bibliográficos
Autores principales: Redenšek, Sara, Jenko Bizjan, Barbara, Trošt, Maja, Dolžan, Vita
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Genetics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6532453/
https://www.ncbi.nlm.nih.gov/pubmed/31156712
http://dx.doi.org/10.3389/fgene.2019.00461

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6532453/
https://www.ncbi.nlm.nih.gov/pubmed/31156712
http://dx.doi.org/10.3389/fgene.2019.00461

Ejemplares similares